US 10988465
CXCR4 inhibitors and uses thereof
granted A61KA61K45/06A61P
Quick answer
US patent 10988465 (CXCR4 inhibitors and uses thereof) held by X4 Pharmaceuticals, Inc. expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- X4 Pharmaceuticals, Inc.
- Grant date
- Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K45/06, A61P, A61P35/00